ONCE visits IBEC to learn about the research in bioengineering for health
Àngels López
Bioengineering to treat diabetes in the media
Researchers from the Institute for Bioengineering of Catalonia (IBEC) led by ICREA Research Professor Javier Ramón, appear in the media for a recent study in collaboration with IDIBAPS researchers, in which they have developed small spheres capable of responding to variations in the levels glucose and produce insulin in vitro.
BRIGHTER on the radio
Elena Martínez, main researcher at IBEC, appears on radio 5, from RTVE, for her research on the creation of artificial skin that could be used to replace some animal experimentation methods.
IBECer James Eills wins the Erwin Schrödinger Prize
BIST-FBA Fellow at IBEC, Dr. James Eills, is part of an international team that has received the Erwin Schrödinger Prize. Eills, current Postdoc at the Group of Irene Marco at IBEC, contributed in Germany to a technique that amplifies magnetic resonance signals.
Josep Samitier, technology and health on “Ràdio Estel”
Josep Samitier, director of the Institute for Bioengineering of Catalonia, is interviewed on the program “Tot anirà bé” of “Ràdio Estel” for the technological and health advances that are being carried out at IBEC.
Progress towards the regeneration of the human retina
The media have published the new discovery made by scientists from the Center for Genomic Regulation (CRG) and financed mainly by a CaixaResearch Health Research Project of the Fundació “la Caixa” awarded to Pia Cosma (CRG), Nuria Montserrat (IBEC) and Justin Christopher D’Antin (Barraquer).
Innovative bioengineered spheres might help treating diabetes
Researchers from IBEC, in collaboration with IDIBAPS in Barcelona, have developed nontoxic small spheres able to respond to variations in glucose levels, and producing insulin in vitro. These biomimetic spheroids containing pancreatic β-cells were prepared based on 3D bioprinting. This approach might help in the future improving clinical outcomes of β-cell transplantation strategies for diabetes treatment, as well as for in vitro drug screening platforms.
Cell fusion ‘awakens’ regenerative potential of human retina
Fusing human retinal cells with adult stem cells could be a potential therapeutic strategy to treat retinal damage and visual impairment, according to the findings of a new study published in the journal eBioMedicine, with participation of Nuria Montserrat´s Group at IBEC. The hybrid cells act by awakening the regenerative potential of human retinal tissue, previously only thought to be the preserve of cold-blood vertebrates.
Núria Montserrat and gender equality at BWAW
Núria Montserrat, ICREA Research Professor and group leader at the Institute for Bioengineering of Catalonia (IBEC), appears in the media for her participation in the round table of the Barcelona Woman Acceleration Week 2022 (BWAW).
IBEC renews the accreditation ‘HR Excellence in Research’ from the European Commission
